Cargando…
Evolution of clinical guidelines for antimicrobial management of Clostridioides difficile infection
Clostridioides difficile infection (CDI) has been an epidemic for many years. Our biggest challenge in treating CDI is preventing recurrence, which is seen in approximately 25% of patients with initial infection and in 40–60% of those with subsequent episodes. Given the major disease burden of this...
Autores principales: | Chaar, Abdelkader, Feuerstadt, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111514/ https://www.ncbi.nlm.nih.gov/pubmed/33995583 http://dx.doi.org/10.1177/17562848211011953 |
Ejemplares similares
-
Clostridioides difficile infection: curbing a difficult
menace
por: Khanna, Sahil, et al.
Publicado: (2022) -
Epidemiology of community-acquired and recurrent Clostridioides difficile infection
por: Fu, Yichun, et al.
Publicado: (2021) -
The interplay of Clostridioides difficile
infection and inflammatory bowel disease
por: Sehgal, Kanika, et al.
Publicado: (2021) -
Transitions of care in Clostridioides difficile infection: a need of the hour
por: Khanna, Sahil, et al.
Publicado: (2022) -
The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection
por: Mullish, Benjamin H., et al.
Publicado: (2021)